Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Chlamydia trachomatis Stories

2013-12-05 13:47:07

Novel simultaneous RNA-Seq analysis tracks host/pathogen interactions Investigators at the Institute for Genome Sciences at the University of Maryland School of Medicine have developed a new technique that can track the activity of a disease-causing microbe and the host cell response to that pathogen simultaneously. Using the new method to examine Chlamydia trachomatis infection, the study team observed how the response of the infected cell contributes to one of the hallmark outcomes of...

2012-09-11 02:29:04

HAMILTON, N.J., Sept. 11, 2012 /PRNewswire/ -- Medical Diagnostic Laboratories, L.L.C. (MDL), a CLIA-certified infectious disease laboratory which specializes in high complexity, state-of-the-art, automated DNA-based molecular analyses, announced that it is now offering an azithromycin resistance reflex assay for Chlamydia trachomatis. MDL is believed to be the first and only clinical laboratory to offer the antibiotic resistance for this sexually transmitted pathogen. Drug resistance testing...

78462058
2012-03-13 07:56:05

A recent study posted in Nature Genetics explains that researchers have found that Chlamydia has been evolving differently than previously thought. The researchers used whole genome sequencing to find these results. Their findings show the exchange of DNA between different strains of the STD to form new strains is more common than expected. The researchers came about their findings while working with hospitals to improve their testing and detection of Chlamydia, particularly different...

2012-03-12 09:57:18

Whole genome analysis of Chlamydia trachomatis highlights risks with current method of tracking In a study released today in Nature Genetics, researchers have found that Chlamydia has evolved more actively than was previously thought. Using whole genome sequencing the researchers show that the exchange of DNA between different strains of Chlamydia to form new strains is much more common than expected. The team highlights that current clinical testing methods do not capture the variation...

2011-12-22 07:26:04

A New UCSF Study Shows Same Result Can Be Achieved with Half the Antibiotics A UCSF study shows a popular treatment for a potentially blinding eye infection is just as effective if given every six months versus annually. This randomized study on trachoma, the leading cause of infection-caused blindness in the world, could potentially treat twice the number of patients using the same amount of medication. “The idea is we can do more with less,” said Bruce Gaynor, MD,...

2011-10-13 11:28:28

A breakthrough in the study of chlamydia genetics could open the way to new treatments and the development of a vaccine for this sexually transmitted disease. For decades research progress has been hampered because scientists have been prevented from fully understanding these bacteria as they have been unable to manipulate the genome of Chlamydia trachomatis. Now researchers in Southampton have made a significant breakthrough in accessing the chlamydial genome and believe it could pave...

2011-10-13 05:31:05

(Ivanhoe Newswire) — A weakened strain of Chlamydia trachomatis bacteria may be used as a vaccine to prevent or reduce the severity of trachoma, the world´s leading cause of infectious blindness, according to this study conducted on monkeys. "This work is an important milestone in the development of a trachoma vaccine," Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID) at NIH, was quoted as saying. "If this approach...

2011-10-10 09:25:53

NIH - developed vaccine based on live, attenuated Chlamydia bacteria An attenuated, or weakened, strain of Chlamydia trachomatis bacteria can be used as a vaccine to prevent or reduce the severity of trachoma, the world's leading cause of infectious blindness, suggest findings from a National Institutes of Health study in monkeys. "This work is an important milestone in the development of a trachoma vaccine," noted Anthony S. Fauci, M.D., director of the National Institute of Allergy...

2011-10-07 11:04:10

A novel mechanism has been identified in which Chlamydia trachomatis tricks host cells into taking up the bacteria. Researchers from University of California San Francisco, led by Joanne Engel, report their findings in the Open Access journal PLoS Pathogens on October 6th. Dr. Engel and colleagues show that Chlamydia coat themselves with a growth factor made by the cells of the organism they are infecting. This disguise allows the bacteria to infect cells, much like a Trojan horse. Once...

2011-05-06 16:16:00

PLEASANTON, Calif., May 6, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has filed for FDA clearance of its Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) tests. When cleared this standardized and fully automated test will help physicians detect and subsequently treat patients with the disease. Clinical trial data will be presented at the 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID, May 7-13, Milan, Italy)...